Sheraz Ch
1DANA Brain Health Institute, Iranian Neuroscience Society-Fars Chapter, Shiraz, Iran 2Senses Cultural Foundation, Sacramento, CA, USA
Research Expertise
Publications
Neural communication through theta-gamma cross-frequency coupling in a bistable motion perception task
Journal of Integrative Neuroscience / Dec 01, 2016
Alipour, A., Mojdehfarahbakhsh, A., Tavakolian, A., Morshedzadeh, T., Asadi, M., Mehdizadeh, A., & Nami, M. (2016). Neural communication through theta-gamma cross-frequency coupling in a bistable motion perception task. Journal of Integrative Neuroscience, 15(04), 539–551. https://doi.org/10.1142/s0219635216500291
An MRI-based Deep Learning Model to Predict Parkinson’s Disease Stages
Feb 23, 2021
Mozhdehfarahbakhsh, A., Chitsazian, S., Chakrabarti, P., Chakrabarti, T., Kateb, B., & Nami, M. (2021). An MRI-based Deep Learning Model to Predict Parkinson’s Disease Stages. https://doi.org/10.1101/2021.02.19.21252081
A Convolutional Neural Network Model to Differentiate Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder Based on the Resting State fMRI Data
Mar 03, 2021
Mozhdehfarahbakhsh, A., Moloodi, A., Chakrabarti, P., Rao, K. J., Kateb, B., & Nami, M. (2021). A Convolutional Neural Network Model to Differentiate Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder Based on the Resting State fMRI Data. https://doi.org/10.31219/osf.io/6rksw
Studies on the Bottom-Up and Top-Down Neural Information Flow Alterations in Neurodegeneration
Journal of Alzheimer's Disease / Oct 27, 2020
Alipour, A., Mozhdehfarahbakhsh, A., Nouri, S., Petramfar, P., Tahamtan, M., Kamali, A.-M., Rao, K. S., & Nami, M. (2020). Studies on the Bottom-Up and Top-Down Neural Information Flow Alterations in Neurodegeneration. Journal of Alzheimer’s Disease, 78(1), 169–183. https://doi.org/10.3233/jad-200590
A Neural Network Model of Top-Down Rivalry
Binocular Rivalry / Jan 01, 2004
A Neural Network Model of Top-Down Rivalry. (2004). Binocular Rivalry. https://doi.org/10.7551/mitpress/1605.003.0020
Exploring Australian pharmacists’ perceptions and practices towards reducing the risk of medicines-related harm in aged care residents
Frontiers in Pharmacology / Mar 01, 2023
Ali, S., Curtain, C. M., Peterson, G. M., & Salahudeen, M. S. (2023). Exploring Australian pharmacists’ perceptions and practices towards reducing the risk of medicines-related harm in aged care residents. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1131456
A Survey of Saudi General Practitioners on the Use of Thromboprophylaxis Guidelines and Risk Assessment Tools in Atrial Fibrillation
Clinics and Practice / Feb 23, 2023
Alnami, M. I., Alsalim, A. M., Alhakeem, R. F., Al-Somali, B. A., Bahkali, H. A., Alhabshi, H. A., Alotaibi, H. T., Alqallaf, R. A., & Ali, S. (2023). A Survey of Saudi General Practitioners on the Use of Thromboprophylaxis Guidelines and Risk Assessment Tools in Atrial Fibrillation. Clinics and Practice, 13(2), 347–356. https://doi.org/10.3390/clinpract13020031
Awareness of Cardiovascular Disease Risk Factors by Community Pharmacists in Saudi Arabia
Healthcare / Jan 04, 2023
Sulaiteen, F. M., Al-Zaagi, I. A., Alenazi, M. S., Alotaibi, A. Z., Alghamdi, T. A., Yousaf, A., & Ali, S. (2023). Awareness of Cardiovascular Disease Risk Factors by Community Pharmacists in Saudi Arabia. Healthcare, 11(2), 151. https://doi.org/10.3390/healthcare11020151
Hospital pharmacists’ awareness and perspective toward the management of COVID-19 pandemic in the Kingdom of Saudi Arabia
Pharmacy Practice / Sep 23, 2022
Salem Al-Dossari, D., Abdulaziz Al-Zaagi, I., Bamogaddam, R. F., Hamoud Alnajrani, R., Rashid Alnajrani, N., Najib Alajami, H., Abdullah AlOtaibi, R., AlShammary, K. S., AlOtaibi, A. J., Yousaf, A., & Ali, S. (2022). Hospital pharmacists’ awareness and perspective toward the management of COVID-19 pandemic in the Kingdom of Saudi Arabia. Pharmacy Practice, 20(3), 01–07. https://doi.org/10.18549/pharmpract.2022.3.2709
Actual drug-related harms in residential aged care facilities: a narrative review
Expert Opinion on Drug Safety / Jun 02, 2022
Ali, S., Curtain, C. M., Bereznicki, L. RE., & Salahudeen, M. S. (2022). Actual drug-related harms in residential aged care facilities: a narrative review. Expert Opinion on Drug Safety, 21(8), 1047–1060. https://doi.org/10.1080/14740338.2022.2084071
Effectiveness of Interventions to Improve the Anticholinergic Prescribing Practice in Older Adults: A Systematic Review
Journal of Clinical Medicine / Jan 28, 2022
Salahudeen, M. S., Alfahmi, A., Farooq, A., Akhtar, M., Ajaz, S., Alotaibi, S., Faiz, M., & Ali, S. (2022). Effectiveness of Interventions to Improve the Anticholinergic Prescribing Practice in Older Adults: A Systematic Review. Journal of Clinical Medicine, 11(3), 714. https://doi.org/10.3390/jcm11030714
Pharmacist‐led interventions to reduce adverse drug events in older people living in residential aged care facilities: A systematic review
British Journal of Clinical Pharmacology / Apr 20, 2021
Ali, S., Salahudeen, M. S., Bereznicki, L. R. E., & Curtain, C. M. (2021). Pharmacist‐led interventions to reduce adverse drug events in older people living in residential aged care facilities: A systematic review. British Journal of Clinical Pharmacology, 87(10), 3672–3689. Portico. https://doi.org/10.1111/bcp.14824
Knowledge and Barriers Among Physicians Toward Adverse Drug Reaction Reporting at a Tertiary Care Hospital in Saudi Arabia
Hospital Pharmacy / Mar 04, 2020
Al-Abdulkarim, D. A., Aljadhey, H. S., Mahmoud, M. A., Poff, G. A., Hassali, M. A., & Ali, S. (2020). Knowledge and Barriers Among Physicians Toward Adverse Drug Reaction Reporting at a Tertiary Care Hospital in Saudi Arabia. Hospital Pharmacy, 56(4), 368–373. https://doi.org/10.1177/0018578720910385
Magnitude and characteristics of clinical trials in the Kingdom of Saudi Arabia: A cross-sectional analysis
Contemporary Clinical Trials Communications / Sep 01, 2017
Ali, S., Alghamdi, M. A., Alzhrani, J. A., & De Vol, E. B. (2017). Magnitude and characteristics of clinical trials in the Kingdom of Saudi Arabia: A cross-sectional analysis. Contemporary Clinical Trials Communications, 7, 126–129. https://doi.org/10.1016/j.conctc.2017.05.008
Education
University of Eastern Finland
Masters in Public Health (MPH) / December, 2014
Baqai Medical University
Doctor of Pharmacy (PharmD) / April, 2011
Experience
University of Tasmania, Australia
PhD Research Scholar / March, 2020 — Present
Ministry of Health
Head of Scientific and Staff Development / July, 2019 — February, 2020
Researcher / November, 2015 — February, 2020
London School of Hygiene and Tropical Medicine
Co-investigator, CRASH-3 Study / May, 2016 — September, 2017
Join Sheraz on NotedSource!
Join Now
At NotedSource, we believe that professors, post-docs, scientists and other researchers have deep, untapped knowledge and expertise that can be leveraged to drive innovation within companies. NotedSource is committed to bridging the gap between academia and industry by providing a platform for collaboration with industry and networking with other researchers.
For industry, NotedSource identifies the right academic experts in 24 hours to help organizations build and grow. With a platform of thousands of knowledgeable PhDs, scientists, and industry experts, NotedSource makes connecting and collaborating easy.
For academic researchers such as professors, post-docs, and Ph.D.s, NotedSource provides tools to discover and connect to your colleagues with messaging and news feeds, in addition to the opportunity to be paid for your collaboration with vetted partners.
Expert Institutions
Proudly trusted by
